Top

Published in:

Open Access 01-01-2010 | Original Contribution

Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis

Authors: Marina Dunaeva, Stefan Voo, Carolien van Oosterhoud, Johannes Waltenberger

Published in: Basic Research in Cardiology | Issue 1/2010

Abstract

The aim of the present study was to evaluate the expression of hedgehog (Hh) signaling molecules and the chemotactic activity of Sonic hedgehog (Shh) in monocytes from control (CTR) and diabetic patients with or without coronary artery disease (CAD). Previously several studies demonstrated that exogenous administration of Shh can induce angiogenesis and accelerate repair of ischemic myocardium and skeletal muscles. Blood samples were collected from (1) CTR (n = 25); (2) patients with stable CAD without diabetes mellitus (CAD−DM, n = 10); and (3) with stable CAD with DM (CAD+DM, n = 15). Monocytes were isolated by Percoll gradient and subjected to PCR and chemotaxis analysis. Hh signaling molecules were expressed in human monocytes, and Shh-induced monocyte chemotaxis. Shh-stimulated migration of monocytes from CTR measured 172.5 ± 90% and a maximal stimulation was observed at Shh concentration of 1 μg/ml. However, Shh failed to induce migration of monocytes from CAD+DM (94.3 ± 27%, P < 0.001 vs. CTR). The impaired response to Shh was associated with strong transcriptional upregulation of the receptor Ptc, while expression of downstream molecules was not altered. Moreover, Ptc is strongly expressed in macrophages of human aortic atherosclerotic plaque. Thus, Shh is a potent chemoattractant for monocytes and it activates classical signaling pathways related to migration. The Shh signaling was negatively affected by DM which might be involved in the pathogenesis of DM-related complications.

Asai J, Takenaka H, Kusano K, Ii M, Luedemann C, Curry C, Eaton E, Iwakura A, Tsutsumi Y, Hamada H, Kishimoto S, Thorne T, Kishore R, Losordo D (2006) Topical sonic hedgehog gene therapy accelerates wound healing in diabetes by enhancing endothelial progenitor cell-mediated microvascular remodeling. Circulation 113:2413–2424CrossRefPubMed

Barleon B, Sozzani S, Zhou D, Weich H, Mantovani A, Marmé D (1996) Migration of human monocytes in response to vascular endothelial growth factor (VEGF) is mediated via the VEGF receptor flt-1. Blood 87:3336–3343PubMed

Beckers L, Heeneman S, Wang L, Burkly L, Rousch M, Davidson N, Gijbels M, de Winther M, Daemen M, Lutgens E (2007) Disruption of hedgehog signalling in ApoE−/− mice reduces plasma lipid levels, but increases atherosclerosis due to enhanced lipid uptake by macrophages. J Pathol 212:420–428CrossRefPubMed

Bhardwaj G, Murdoch B, Wu D, Baker D, Williams K, Chadwick K, Ling L, Karanu F, Bhatia M (2001) Sonic hedgehog induces the proliferation of primitive human hematopoietic cells via BMP regulation. Nat Immunol 2:172–180CrossRefPubMed

Bouma G, Coppens J, Lam-Tse W, Luini W, Sintnicolaas K, Levering W, Sozzani S, Drexhage H, Versnel M (2005) An increased MRP8/14 expression and adhesion, but a decreased migration towards proinflammatory chemokines of type 1 diabetes monocytes. Clin Exp Immunol 141:509–517CrossRefPubMed

Charron F, Stein E, Jeong J, McMahon AP, Tessier-Lavigne M (2003) The morphogen sonic hedgehog is an axonal chemoattractant that collaborates with netrin-1 in midline axon guidance. Cell 113:11–23CrossRefPubMed

Chen Y, Li X, Tian L, Lui V, Dallman M, Lamb J, Tam P (2007) Inhibition of sonic hedgehog signaling reduces chronic rejection and prolongs allograft survival in a rat orthotopic small bowel transplantation model. Transplantation 83:1351–1357CrossRefPubMed

Chen J, Taipale J, Cooper M, Beachy P (2002) Inhibition of Hedgehog signaling by direct binding of cyclopamine to Smoothened. Genes Dev 16:2743–2748CrossRefPubMed

Cipolletta C, Ryan K, Hanna E, Trimble E (2005) Activation of peripheral blood CD14+ monocytes occurs in diabetes. Diabetes 549:2779–2786CrossRef

10.

Cohen M (2003) The hedgehog signaling network. Am J Med Genetics 123:5–28CrossRef

11.

Cousin W, Fontaine C, Dani C, Peraldi P (2007) Hedgehog and adipogenesis: fat and fiction. Biochimie 89:1447–1453CrossRefPubMed

12.

Deshpande G, Swanhart L, Chiang P, Schedl P (2001) Hedgehog signaling in germ cell migration. Cell 106:759–769CrossRefPubMed

13.

Dyer M, Farrington S, Mohn D, Munday J, Baron M (2001) Indian hedgehog activates hematopoiesis and vasculogenesis and can respecify prospective neurectodermal cell fate in the mouse embryo. Development 128:1717–1730PubMed

14.

Fan L, Pepicelli C, Dibble C, Catbagan W, Zarycki J, Laciak R, Gipp J, Shaw A, Lamm M, Munoz A, Lipinski R, Thrasher J, Bushman W (2004) Hedgehog signaling promotes prostate xenograft tumor growth. Endocrinology 145:3961–3970CrossRefPubMed

15.

Frantz S, Vincent K, Feron O, Kelly R (2005) Innate immunity and angiogenesis. Circ Res 96:15–26CrossRefPubMed

16.

Freedman R, Ma Q, Wang E, Gallardo S, Gordon I, Shin J, Jin P, Stroncek D, Marincola F (2008) Migration deficit in monocyte-macrophages in human ovarian cancer. Cancer Immunol Immunother 57:635–645CrossRefPubMed

17.

Fu J, Liu W, Zhou J, Sun H, Xu H, Luo L, Zhang H, Zhou YF (2006) Sonic hedgehog protein promotes bone marrow-derived endothelial progenitor cell proliferation, migration and VEGF production via PI 3-kinase/Akt signaling pathways. Acta Pharmacol Sin 27:685–693CrossRefPubMed

18.

Hochman E, Castiel A, Jacob-Hirsch J, Amariglio N, Izraeli S (2006) Molecular pathways regulating pro-migratory effects of Hedgehog signaling. J Biol Chem 281:33860–33870CrossRefPubMed

19.

Kamps A, Coffman C (2005) G protein-coupled receptor roles in cell migration and cell death decisions. Ann N Y Acad Sci 1049:17–23CrossRefPubMed

20.

Katz S, Klein B, Fishman P, Djaldetti M (1983) Phagocytotic activity on monocytes from diabetic patients. Diabetes Care 6:479–482CrossRefPubMed

21.

Kusano K, Pola R, Murayama T, Curry C, Kawamoto A, Iwakura A, Shintani S, Ii M, Asai J, Tkebuchava T, Thorne T, Takenaka H, Aikawa R, Goukassian D, von Samson P, Hamada H, Yoon YS, Silver M, Eaton E, Ma H, Heyd L, Kearney M, Munger W, Porter JA, Kishore R, Losordo DW (2005) Sonic hedgehog myocardial gene therapy: tissue repair through transient reconstitution of embryonic signaling. Nat Med 11:1197–1204CrossRefPubMed

22.

Lavine K, White A, Park C, Smith C, Choi K, Long F, Hui C, Ornitz D (2006) Fibroblast growth factor signals regulate a wave of Hedgehog activation that is essential for coronary vascular development. Genes Dev 20:1651–1666CrossRefPubMed

23.

Lowrey J, Stewart G, Lindey S, Hoyne G, Dallman M, Howie S, Lamb J (2002) Sonic hedgehog promotes cell cycle progression in activated peripheral CD4(+) T lymphocytes. J Immunol 169:1869–1875PubMed

24.

Merchán P, Bribián A, Sánchez-Camacho C, Lezameta M, Bovolenta P, de Castro F (2007) Sonic hedgehog promotes the migration and proliferation of optic nerve oligodendrocyte precursors. Mol Cell Neurosci 36:355–368CrossRefPubMed

25.

Morrow D, Sweeney C, Birney Y, Guha S, Collins N, Cummins P, Murphy R, Walls D, Redmond E, Cahill P (2007) Biomechanical regulation of hedgehog signaling in vascular smooth muscle cells in vitro and in vivo. Am J Physiol Cell Physiol 292:C488–C496CrossRefPubMed

26.

O’Brien B, Huang Y, Geng X, Dutz J, Finegood D (2002) Phagocytosis of apoptotic cells by macrophages from NOD mice is reduced. Diabetes 51:2481–2488CrossRefPubMed

27.

Pathi S, Pagan-Westphal S, Baker D, Garber E, Rayhorn P, Bumcrot D, Tabin CJ, Blake Pepinsky R, Williams KP (2001) Comparative biological responses to human Sonic, Indian, and Desert hedgehog. Mech Dev 106:107–117CrossRefPubMed

28.

Pepinsky R, Zeng C, Wen D, Rayhorn P, Baker D, Williams K, Bixler S, Ambrose C, Garber E, Miatkowski K, Taylor F, Wang E, Galdes A (1998) Identification of a palmitic acid-modified form of human Sonic hedgehog. J Biol Chem 273:14037–14045CrossRefPubMed

29.

Pola R, Ling L, Silver M, Corbley M, Kearney M, Blake Pepinsky R, Shapiro R, Taylor F, Baker D, Asahara T, Isner J (2001) The morphogen Sonic hedgehog is an indirect angiogenic agent upregulating two families of angiogenic growth factors. Nat Med 7:706–711CrossRefPubMed

30.

Porter J, Young K, Beachy P (1996) Cholesterol modification of hedgehog signaling proteins in animal development. Science 274:255–259CrossRefPubMed

31.

Riobo N, Lu K, Ai X, Haines G, Emerson C (2006) Phosphoinositide 3-kinase and Akt are essential for Sonic hedgehog signaling. Proc Natl Acad Sci USA 103:4505–4510CrossRefPubMed

32.

Schaper W, Scholz D (2003) Factors regulating arteriogenesis. Arterioscler Thromb Vasc Biol 23:1143–1151CrossRefPubMed

33.

Shinozaki S, Ohnishi H, Hama K, Kita H, Yamamoto H, Osawa H, Sato K, Tamada K, Mashima H, Sugano K (2008) Indian hedgehog promotes the migration of rat activated pancreatic stellate cells by increasing membrane type-1 matrix metalloproteinase on the plasma membrane. J Cell Physiol 216:38–46CrossRefPubMed

34.

Stephens L, Ellson C, Hawkins P (2002) Roles of PI3Ks in leukocyte chemotaxis and phagocytosis. Curr Opin Cell Biol 14:203–213CrossRefPubMed

35.

Stewart G, Hoyne G, Ahmad S, Jarman E, Wallace W, Harrison D, Haslett C, Lamb J, Howie S (2003) Expression of the developmental Sonic hedgehog (Shh) signalling pathway is up-regulated in chronic lung fibrosis and the Shh receptor patched 1 is present in circulating T lymphocytes. J Pathol 199:488–495CrossRefPubMed

36.

Taipale J, Cooper M, Maiti T, Beachy P (2002) Patched acts catalytically to suppress the activity of Smoothened. Nature 418:892–897CrossRefPubMed

37.

Taylor F, Wen D, Garber E, Carmillo A, Baker D, Arduini R, Williams KP, Weinreb PH, Rayhorn P, Hronowski X, Whitty A, Day ES, Boriack-Sjodin A, Shapiro RI, Galdes A, Pepinsky RB (2001) Enhanced potency of human Sonic hedgehog by hydrophobic modification. Biochemistry 40:4359–4371CrossRefPubMed

38.

Wakelin S, Forsythe J, Garden O, Howie S (2008) Commercially available recombinant sonic hedgehog up-regulates Ptc and modulates the cytokine and chemokine expression of human macrophages: an effect mediated by endotoxin contamination? Immunobiology 213:25–38CrossRefPubMed

39.

Waltenberger J (2001) Impaired collateral development in diabetes: potential cellular mechanisms and therapeutic implications. Cardiovasc Res 49:554–560CrossRefPubMed

40.

Waltenberger J, Lange J, Kranz A (2000) Vascular endothelial growth factor-A-induced chemotaxis of monocytes is attenuated in patients with diabetes mellitus: a potential predictor for the individual capacity to develop collaterals. Circulation 102:185–190PubMed

41.

Watkins D, Berman D, Burkholder S, Wang B, Beachy P, Baylin S (2003) Hedgehog signalling within airway epithelial progenitors and in small-cell lung cancer. Nature 422:313–317CrossRefPubMed

42.

Werner G, Richartz B, Heinke S, Ferrari M, Figulla H (2003) Impaired acute collateral recruitment as a possible mechanism for increased cardiac adverse events in patients with diabetes mellitus. Eur Heart J 24:1134–1142CrossRefPubMed

43.

Zernecke A, Weber C (2005) Inflammatory mediators in atherosclerotic vascular disease. Basic Res Cardiol 100:93–101CrossRefPubMed

44.

Zhang C (2008) The role of inflammatory cytokines in endothelial dysfunction. Basic Res Cardiol 103:398–406CrossRefPubMed

Title: Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis
Authors: Marina Dunaeva
Stefan Voo
Carolien van Oosterhoud
Johannes Waltenberger
Publication date: 01-01-2010
Publisher: D. Steinkopff-Verlag
Published in: Basic Research in Cardiology / Issue 1/2010
Print ISSN: 0300-8428
Electronic ISSN: 1435-1803
DOI: https://doi.org/10.1007/s00395-009-0047-x

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

At a glance: The STEP trials

Springer Medicine

Sonic hedgehog is a potent chemoattractant for human monocytes: diabetes mellitus inhibits Sonic hedgehog-induced monocyte chemotaxis

Abstract

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 1/2010

Long-term treatment with the AT1-receptor antagonist telmisartan inhibits biglycan accumulation in murine atherosclerosis

Propylthiouracil, independent of its antithyroid effect, promotes vascular smooth muscle cells differentiation via PTEN induction

AMP579 is revealed to be a potent A2b-adenosine receptor agonist in human 293 cells and rabbit hearts

Proteasome inhibitor bortezomib promotes a rupture-prone plaque phenotype in ApoE-deficient mice

Humoral anti-proteasomal autoimmunity in dilated cardiomyopathy

Adrenomedullin is increased in alveolar macrophages and released from the lungs into the circulation in severe heart failure

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page